alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT
      32.1**





**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER**


**AND
      CHIEF FINANCIAL OFFICER**


**PURSUANT
      TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**




SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002




In
      connection with the Quarterly Report of Tiens Biotech Group (USA), Inc. (the
      “Registrant”) on Form 10-Q for the three months ended March 31, 2008 as filed
      with the Securities and Exchange Commission (the “Report”), each of the
      undersigned, Jinyuan Li, Chief Executive Officer and Chairman of the Registrant,
      and Wenjun Jiao, Chief Financial Officer of the Registrant, certifies, pursuant
      to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley
      Act
      of 2002, that, to the best of his knowledge:




1.
      The
      Report fully complies in all material respects with the requirements of Section
      13(a) or 15(d) of the Securities Exchange Act of 1934; and




2.
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Registrant as of and
      for the period covered by the Report.




Pursuant
      to the rules and regulations of the Securities and Exchange Commission, this
      certification is being furnished and is not deemed filed.





Date:
      May
      15, 2008





/s/
                Jinyuan LiJinyuan
                LiChief
                Executive Officer and President(Principal
                Executive Officer)





Date:
      May
      15, 2008





/s/
                Wenjun JiaoWenjun
                JiaoChief
                Financial Officer(Principal
                Accounting Officer)
EXHIBIT 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Lease Equity Appreciation Fund I, L.P. (the “Company”) on Form 10-Q for the quarter ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert K. Moskovitz, Chief Financial Officer of the General Partner of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:  May 16, 2011
/s/ Robert K. MoskovitzName: Robert K. MoskovitzTitle: Chief Financial Officer of the General Partner
Order entered January 11, 2017

In The



## Court of Appeals

Fifth District of Texas at Dallas

No. 05

- 16

- 01374

- CV

IN RE SENRICK WILKER SON, Relator

On Appeal from the Judicial District Court

Dallas Count y, Texas



### O RDER

Based on the Court’s opinion of this date, we DISMISS relator’s November 21, 2016

petition for writ of mandamus

.

/s/ DOUGLAS S. LANG

JUSTICE
exv4w1





Exhibit
4.1





	AWH
REGISTERED SHARES REGISTERED SHARES
INCORPORATED UNDER THE LAWS
OF SWITZERLAND
CUSIP H01531 10 4
SEE REVERSE FOR CERTAIN
DEFINITIONS
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG
THIS IS TO CERTIFY THAT
is the registered holder of
FULLY PAID AND NON-ASSESSABLE REGISTERED SHARES, PAR VALUE US $15.00 PER
SHARE, OF
Allied World Assurance Company Holdings, AG transferable on the records of the Company
by the holder hereof in person or by duly authorized attorney upon surrender of this
certificate properly endorsed. This certificate and the shares represented hereby are issued and
shall be held subject to all the provisions of the Articles of Association and Organizational
Regulations of the Company, copies of which are on file with the Transfer Agent, to all of which
the holder by acceptance hereof assents.
This certificate is not valid unless countersigned and registered by the
Transfer Agent and Registrar. Witness the signatures of the Company’s duly authorized
officers.
Dated
Countersigned and Registered:
CONTINENTAL STOCK TRANSFER & TRUST COMPANY,
(New York, N.Y.) Transfer Agent
and Registrar
By
Authorized Signature CORPORATE SECRETARY CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD





 









 











	ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG
The following abbreviations, when used in the inscription on the face of this certificate,
shall be construed as though they were written out in full according to applicable laws or
regulations:
TEN COM — as tenants in common TEN ENT — as tenants by the entireties
JT TEN — as joint tenants with right of survivorship and not as tenants in common
UNIF GIFT MIN ACT—.Custodian
(Cust) (Minor)
under Uniform Gifts to Minors
Act
(State)
Additional abbreviations may also be used though not in the above list.
For value received, hereby sell, assign and transfer unto
PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE
(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)
shares represented by the within certificate, and do hereby irrevocably constitute and
appoint
Attorney
to transfer the said shares on the books of the within named Company with full power of
substitution in the premises.
Dated
NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE
NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR,
WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.
Signature(s) Guaranteed:
THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS,
STOCKBROKERS, SAVINGS ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15.
Exhibit 11

                        STATEMENT RE COMPUTATION OF PER-SHARE EARNINGS

<TABLE>
<CAPTION>
   
                                                                YEAR ENDED MARCH 31
                                                       1998            1997           1996
                                                    -----------    -----------    -----------
<S>                                                   <C>            <C>            <C>      
Basic and Diluted
Average common shares outstanding                     1,754,342      1,400,423      1,273,274

Net effect of dilutive  stock  options - based on
the  treasury  method  using average market price            --             --             --
                                                    -----------    -----------    -----------
Total                                                 1,754,342      1,400,423      1,273,274
                                                    -----------    -----------    -----------
(Loss) income from continuing operations            $  (206,108)   $   126,731    $  (778,332)
Preferred stock dividends                               162,000        162,000        203,836
                                                    -----------    -----------    -----------

(Loss) income applicable to common stockholders        (368,108)       (35,269)      (982,168)
                                                    ===========    ===========    ===========
    
</TABLE>
##### 



Exhibit 31.1
 
      (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the Fund, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which
the Report is being prepared;(b)
    
    Evaluated the effectiveness of the Funds disclosure controls and procedures
and presented in the Report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the period covered by the Report based on such
evaluation; and(c)
    
    Disclosed in the Report any change in the Funds internal control over
financial reporting that occurred during the Funds most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the Funds internal
control over financial reporting; and
  (a)
    
    all significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the Funds ability to record, process, summarize and report financial
information; and(b)
    
    any fraud, whether or not material, that involves management or other employees
who have a significant role in the Funds internal control over financial reporting.
 By: /s/ Nigel James

Nigel JamesPresident and Principal Executive OfficerMay 15, 2007
 E-2
FIFTH DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________ 

Case No. 5D24-0528 

LT Case No. 2008-CF-13662

_____________________________ 

ANTHONY LEE RUISE, 

Appellant, 

v.

STATE OF FLORIDA, 

Appellee. 

_____________________________ 

3.850 Appeal from the Circuit Court for Duval County. 

Tatiana Salvador, Judge. 

Anthony Lee Ruise, Cross City, pro se. 

Ashley Moody, Attorney General, and Michael McDermott, 

Assistant Attorney General, Tallahassee, for Appellee. 

April 9, 2024 

PER CURIAM.

AFFIRMED. See Fla. R. App. P. 9.315(a). 

EDWARDS, C.J., and MAKAR and BOATWRIGHT, JJ., concur. 
2

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
August 20 , 2015

Manager, Flight Standards Service Unmanned Aircraft Systems Integration Office FAA Headquarters, Building 10A 800 Independence Avenue, SW Washington, DC 20591

Re: Petition to Amend Exemption No. 11253 to Regulatory Docke t No FAA

- 2014

- 0817

for Drone Fleet & Aerospace Management (DFAM) for additional aircraft.

Attention: FAA UAS Integration Office

DFAM respectfully requests the addition of the following aircraft to our Exemption No.

11253 and COA FAA

- 2014

- 0817

- 333E:

Additional Aircraft Requested:

• FreeFly Systems Alta
Note Maybe Eligible for Summary Grant/Amendment by previous FAA Analysis of Exemption No.

12103 ( Docket No. FAA

– 2015

– 0956 )

DFAM’s existin g safety standards and procedures as outlined in our Flight Operation & Procedures Manual (FOPM) will continue for the additional Aircraft. We will follow the recommended Maintenance and Operations Parameters set forth by each of these respective UAV Manu factures.

Please do not hesitate to contact me at the phone number or via the e

- mail address provided above should you have any questions or concerns.

Respectfully submitted,

Simon Nielsen

CEO

, Drone Fleet & Aerospace Management , Inc. Simon Nielsen

CEO Drone Fleet & Aerospace Management, Inc. 606 Venice Blvd, Suite E Venice, CA 90291 (213) 379

- 0629 Simon.Nielsen@drone

- fleet.com

www.drone

- fleet.com
I 

109TH CONGRESS 

2D SESSION H. R. 5513 

To amend part B of title XVIII of the Social Security Act to restore the 

Medicare treatment of ownership of oxygen equipment to that in effect 

before enactment of the Deficit Reduction Act of 2005. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 25, 2006 

Mr. SCHWARZ of Michigan (for himself, Mr. PRICE of Georgia, Mr. REGULA, 

Mr. TIBERI, Mr. HOBSON, and Mr. RYAN of Ohio) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend part B of title XVIII of the Social Security 

Act to restore the Medicare treatment of ownership of 

oxygen equipment to that in effect before enactment 

of the Deficit Reduction Act of 2005. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Home Oxygen Patient 

5 Protection Act of 2006’’. 


rwilkins on PROD1PC63 with BILLS
2 

•HR 5513 IH

1 SEC. 2. RESTORATION OF MEDICARE TREATMENT OF OWN2 ERSHIP OF OXYGEN EQUIPMENT. 

3 (a) IN GENERAL.—Section 1834(a)(5) of the Social 

4 Security Act (42 U.S.C. 1395m(a)(5)), as amended by 

5 section 5101(b) of the Deficit Reduction Act of 2005 

6 (Public Law 109–171), is amended— 

7 (1) in subparagraph (A), by striking ‘‘(E), and 

8 (F)’’ and inserting ‘‘and (E)’’; and 

9 (2) by striking subparagraph (F). 

10 (b) EFFECTIVE DATE.—The amendments made by 

11 subsection (a) shall take effect on January 1, 2007, and 

12 shall apply to individuals receiving oxygen equipment be13 fore, on, or after December 31, 2005. 

Æ 


rwilkins on PROD1PC63 with BILLS
EXHIBIT 32

    CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Yosemite Mortgage Fund II, LLC (the
"Issuer") on Form 10-Q for the quarter ended March 31, 2005, filed with the
Securities and Exchange Commission on or about the date hereof, I, Steven M.
Pontes, General Manager of MFP Management LLC, the Manager of the Issuer, and
the equivalent of the chief executive officer and chief financial officer of the
Issuer, certify that the Report on Form 10-Q containing the financial statements
of the Issuer fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934 ( 15U.S.C. 78m(a) or 78o(d) and that
information contained in the periodic report fairly presents, in all material
respects, the financial condition and results of operations of the Issuer.

Date: May 14, 2005

                                        /S/ STEVEN M. PONTES
                                        ----------------------------------------
                                        Steven M. Pontes
                                        General Manager
                                        MFP Management LLC, Manager [Title]
                                        Principal Executive Officer
                                        Principal Financial Officer
# NCBC Newsroom

Joomla! - the dynamic portal engine and content management system

- NCBC director delivers keynote address at senior seminar for counterproliferation-focused U.S. Army officers Dr. Alan MacDougall, director of the National Counterproliferation and Biosecurity Center, spoke with a group of senior U.S. Army officers who specialize in nuclear and counter-WMD efforts during a U.S. Army Nuclear and Countering WMD Agency professional development seminar on Feb. 2.&nbsp;
Motion Granted; Order filed December 31, 2019 

In The

Fourteenth Court of Appeals

____________

NO. 14-19-00792-CV

____________

JASON DEYO, Appellant

V.

CHAD DWAYNE BRADSHAW, KENNETH RANDAL HUFSTETLER AND 

THE STATE OF TEXAS, Appellees

On Appeal from the 239th District Court

Brazoria County, Texas

Trial Court Cause No. 103573-CV

ORDER

On December 3, 2019, appellees filed a motion strike the reporter’s record 

filed by appellant on November 26, 2019. Appellees’ motion is granted, and the 

reporter’s record filed on November 26, 2019 is struck from this case.

PER CURIAM

Panel Consists of Justices Zimmerer, Spain, and Hassan.
Jermaine GREEN, Appellant, v. STATE of Missouri, Respondent.

WD 80008

Missouri Court of Appeals, Western District.

ORDER FILED: November 14, 2017 Motion for Rehearing and/or Transfer to Supreme Court Denied December 14, 2017

Damien De Loyola, Kansas City, MO, Counsel for Appellant.

Gregory Barnes, Jefferson City, MO, Counsel for Respondent.

Before Division One: Cynthia L. Martin, P.J., James Edward Welsh, and Karen King Mitchell, JJ.

**ORDER**

Per Curiam:

Appellant Jermaine Green ("Green") appeals the judgment of the Circuit Court of Clay County denying after an evidentiary hearing his Rule 24.035 amended motion for post-conviction relief ("Motion"). Green sought to vacate his sentences for first-degree robbery, first-degree assault, and two counts of armed criminal action. As relevant to his appeal, Green argued in his Motion that he received ineffective assistance from plea counsel (Points One and Two), the State committed prosecutorial misconduct (Points Three, Four, and Five), and his right to proportionate sentencing was violated (Point Six). We affirm. A memorandum setting forth the reasons for this order has been provided to the parties. Rule 84.16(b).
Exhibit 32.1



              CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF
                       THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Dahua, Inc. (the "Company") on Form
10-QSB/A for the period ending June 30, 2006, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Younglin Du, CEO and
President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

    (1)   The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

    (2)   The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.



/s/ Yonglin Du
------------------------------
Younglin Du, CEO and President

December 12, 2006
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

October 31, 2006 Clifford W. Taylor, Chief Justice
131590 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 131590 COA: 266448 Wayne CC: 95-012264 DERRICK HUDSON, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, th e application for leave to ap peal the May 17, 2006 order of the Court of Appeals is considered, a nd it is DENIED, because the defendant has failed to meet the burden of establishi ng entitlement to relief under MCR 6.508(D).

s1023 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

October 31, 2006

Clerk
EXHIBIT 31.1

                      CERTIFICATION PURSUANT TO SECTION 302
                        OF THE SARBANES-OXLEY ACT OF 2002


I, David Moskowitz, Chief Executive Officer of GenoMed, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of GenoMed, Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
small  business  issuer as of, and for, the periods  presented in this quarterly
report.

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules  13a-15(e) and 15d-15(e))  for the small business  issuer and
have:

     a.  designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure  that  material  information  relating  to  the  small  business  issuer,
including its  consolidated  subsidiaries,  is made known to us by others within
those entities, particularly during the period in which this quarterly report is
being prepared;

     b. evaluated the  effectiveness of the small business  issuer's  disclosure
controls and procedures and presented in this report our  conclusions  about the
effectiveness  of the disclosure  controls and procedures,  as of the end of the
period covered by this report based on such evaluation; and

5. The small business  issuer's other  certifying  officer and I have disclosed,
based  on  our  most  recent  evaluation  of  internal  control  over  financial
reporting,  to the small business  issuer's  auditors and the audit committee of
the small  business  issuer's  board of  directors  (or persons  performing  the
equivalent functions):

     a. all significant  deficiencies  and material  weaknesses in the design or
operation of internal  controls which are reasonably  likely to adversely affect
the small business  issuer's  ability to record,  process,  summarize and report
financial information; and

     b. any fraud,  whether or not material,  that involves  management or other
employees who have a significant  role in the small business  issuer's  internal
control over financial reporting.

Date:    September 22, 2004


/s/ David Moskowitz
------------------------
David Moskowitz
President and Chief Executive Officer
EXHIBIT
      32.1




Written
      Statement of Principal Executive Officer Furnished Pursuant to


18
      U.S.C.
      Section 1350,


as
      Adopted by


Section
      906 of the Sarbanes-Oxley Act of 2002





In
      connection with the Quarterly Report on Form 10-QSB of HouseRaising, Inc. (the
      "Company") for the quarter ended June 30, 2007 as filed with the Securities
      and
      Exchange Commission on the date hereof (the "Report"), I, Gregory J. Wessling,
      Chairman of the Board and Chief Executive Officer, certify, pursuant to 18
      U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of
      2002, to the best of my knowledge, that:




(1)
      the
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)
      information contained in the Report fairly presents, in all material respects,
      the financial condition as of June 30, 2007 and results of operations for the
      quarter ended June 30, 2007 of the Company and its subsidiaries.




/s/
      Gregory J. Wessling





Gregory
      J. Wessling


Chairman
      of the Board and Chief Executive Officer (Principal Executive
      Officer)





August
      14, 2007





This
      certification accompanies this Report pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
      the
      Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
      Section 18 of the Securities Exchange Act of 1934, as amended.